Obstetrical Care in the ICU Patient

  • A. James Mamary


Learning Objectives After studying this chapter, you should be able to Identify the major causes and incidence of maternal morbidity and mortality. Distinguish the physiologic circulatory and respiratory adaptations of pregnancy from those of disease. Understand aspects of airway management and acute resuscitation unique to pregnant patients. Describe hypertensive disease of pregnancy and its contribution to maternal morbidity and mortality. Recognize the potential role of pregnancy in developing hemorrhagic, cardiogenic, septic, and obstructive shock. Understand diagnostic approaches and treatment of venous thrombosis and thromboembolism in pregnancy. Understand critical illnesses unique to pregnancy such as amniotic fluid embolism, tocolytic-induced pulmonary edema, and ovarian hyperstimulation syndrome.


Pulmonary Arterial Hypertension Acute Respiratory Distress Syndrome Maternal Death Simplified Acute Physiology Score HELLP Syndrome 


  1. 1.
    Plante LA. A curriculum in critical care medicine for maternal-fetal medicine fellows. Crit Care Med. 2006;34:2004-2007.PubMedCrossRefGoogle Scholar
  2. 2.
    el-Solh AA, Grant BJ. A comparison of severity of illness scoring systems for critically ill obstetric patients. Chest. 1996;110:1299-1304.PubMedCrossRefGoogle Scholar
  3. 3.
    Soubra SH, Guntupalli KK. Critical illness in pregnancy: an overview. Crit Care Med. 2005;33:S248-S255.PubMedCrossRefGoogle Scholar
  4. 4.
    Collop NA, Sahn SA. Critical illness in pregnancy: an analysis of 20 patients admitted to a medical intensive care unit. Chest. 1993;103:1548-1552.PubMedCrossRefGoogle Scholar
  5. 5.
    Zeeman GG. Obstetric critical care: a blueprint for improved outcomes. Crit Care Med. 2006;34:S208-S214.PubMedCrossRefGoogle Scholar
  6. 6.
    Jenkins TM, Troiano NH, Graves CR, Baird SM, Boehm FH. Mechanical ventilation in an obstetric population: characteristics and delivery rates. Am J Obstet Gynecol. 2003;188:549-552.PubMedCrossRefGoogle Scholar
  7. 7.
    Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance – United States, 1991–1999. MMWR Surveill Summ. 2003;52:1-8.PubMedGoogle Scholar
  8. 8.
    Clark SL, Cotton DB, Lee W, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol. 1989;161:1439-1442.PubMedGoogle Scholar
  9. 9.
    Yeomans ER, Gilstrap LC III. Physiologic changes in pregnancy and their impact on critical care. Crit Care Med. 2005;33:S256-S258.PubMedCrossRefGoogle Scholar
  10. 10.
    Campbell LA, Klocke RA. Implications for the pregnant patient. Am J Respir Crit Care Med. 2001;163:1051-1054.PubMedGoogle Scholar
  11. 11.
    Munnur U, de Boisblanc B, Suresh MS. Airway problems in pregnancy. Crit Care Med. 2005;33:S259-S268.PubMedCrossRefGoogle Scholar
  12. 12.
    Rasmussen GE, Malinow AM. Toward reducing maternal mortality: the problem airway in obstetrics. Int Anesthesiol Clin. 1994;32:83-101.PubMedGoogle Scholar
  13. 13.
    Martin JN Jr, May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol. 1999;180:1407-1414.PubMedCrossRefGoogle Scholar
  14. 14.
    Weeks AD, Ononge S. The magpie trial. Lancet. 2002;360:1331; author reply 1331-1332.PubMedCrossRefGoogle Scholar
  15. 15.
    Katz L, de Amorim MM, Figueiroa JN, Pinto e Silva JL. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2008;198:283.e1-283.e8.PubMedCrossRefGoogle Scholar
  16. 16.
    Fonseca JE, Mendez F, Catano C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005;193:1591-1598.PubMedCrossRefGoogle Scholar
  17. 17.
    Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med. 2005;33:S340-S346.PubMedCrossRefGoogle Scholar
  18. 18.
    Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol. 2002;23:301-324.PubMedCrossRefGoogle Scholar
  19. 19.
    Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283:1183-1188.PubMedCrossRefGoogle Scholar
  20. 20.
    Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283:1183-1188.PubMedCrossRefGoogle Scholar
  21. 21.
    Guinn DA, Abel DE, Tomlinson MW. Early goal directed therapy for sepsis during pregnancy. Obstet Gynecol Clin North Am. 2007;34:459-479, xi.PubMedCrossRefGoogle Scholar
  22. 22.
    Sheffield JS. Sepsis and septic shock in pregnancy. Crit Care Clin. 2004;20:651-660.PubMedCrossRefGoogle Scholar
  23. 23.
    Hanania NA, Belfort MA. Acute asthma in pregnancy. Crit Care Med. 2005;33:S319-S324.PubMedCrossRefGoogle Scholar
  24. 24.
    Cole DE, Taylor TL, McCullough DM, Shoff CT, Derdak S. Acute respiratory distress syndrome in pregnancy. Crit Care Med. 2005;33:S269-S278.PubMedCrossRefGoogle Scholar
  25. 25.
    Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ III. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697-706.PubMedGoogle Scholar
  26. 26.
    Stone SE, Morris TA. Pulmonary embolism during and after pregnancy. Crit Care Med. 2005;33:S294-S300.PubMedCrossRefGoogle Scholar
  27. 27.
    Winer-Muram HT, Boone JM, Brown HL, Jennings SG, Mabie WC, Lombardo GT. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology. 2002;224:487-492.PubMedCrossRefGoogle Scholar
  28. 28.
    Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J, American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133:844S-886S.Google Scholar
  29. 29.
    Moore J, Baldisseri MR. Amniotic fluid embolism. Crit Care Med. 2005;33:S279-S285.PubMedCrossRefGoogle Scholar
  30. 30.
    Muth CM, Shank ES. Gas embolism. N Engl J Med. 2000;342:476-482.PubMedCrossRefGoogle Scholar
  31. 31.
    Pisani RJ, Rosenow EC 3rd. Pulmonary edema associated with tocolytic therapy. Ann Intern Med. 1989;110:714-718.PubMedGoogle Scholar
  32. 32.
    Rosenow EC III, Myers JL, Swensen SJ, Pisani RJ. Drug-induced pulmonary disease: an update. Chest. 1992;102:239-250.PubMedCrossRefGoogle Scholar
  33. 33.
    Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol. 1995;102:767-772.PubMedCrossRefGoogle Scholar
  34. 34.
    Budev MM, Arroliga AC, Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med. 2005;33:S301-S306.PubMedCrossRefGoogle Scholar
  35. 35.
    Guntupalli SR, Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med. 2005;33:S332-S339.PubMedCrossRefGoogle Scholar

Additional Reading

  1. Gabbe SG, Niebyl JR, Simpson JL, et al., eds. Obstetrics: Normal and Problem Pregnancies. 5th ed. Philadelphia: Churchill Livingstone; 2007.Google Scholar
  2. Katz VL, Lobo RA, Lentz G, Gershenson D. Comprehensive Gynecology. 5th ed. Philadelphia: Mosby; 2007.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • A. James Mamary
    • 1
  1. 1.Division of Pulmonary and Critical CareTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations